Here, the collected results emphasize the paradoxical role of TMZ that counteracts itself efficacy by increasing COX-2 levels and highlight the crucial role of the COX-2/PGE2/OPN axis as an attractive and potent therapeutic target for GBM treatment. The gene discussed is SPP1; the disease is glioblastoma.